Paper defines the mechanism by which COUR Nanoparticles induce antigen-specific immune toleranceCHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company ...
New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Communication between parasites and their hosts is a central determinant of infection outcome, shaping parasite survival, tissue tropism, immune modulation, ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.
Ianalumab targets the BAFF receptor, depleting malignant B cells and enhancing ibrutinib's efficacy, offering a potential ...
A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...
Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to ...
A new trial found that a progesterone-mimicking drug used to manage hot flashes and other symptoms may have anticancer ...
Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...
GMCL1-dependent degradation of 53BP1 suppresses mitotic surveillance, tuning p53 activation thresholds that govern cell fate decisions and cellular responses after mitosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results